36th Remington
Winter Course in Infectious Diseases

February 21-26, 2010
Cascade Conference Center • Vail, Colorado

Introduction / General Information

Course Description
Thirty-five years ago, this program was developed in an effort to contribute high-quality medical and scientific information and to provide continuing medical education to physicians. This high level of education has continued and has now evolved into one of the premier infectious diseases meetings in the United States. This year, we will pay special attention to the treatment of infection in the transplant recipient; therapies and issues associated with infection in oncology patients; approaches to fungal infections; pathogenesis and treatment of surgical implant infections; the management of HIV infections; and emerging infections due gens

Needs Assessment
The importance of infectious diseases in health and medical care has increasingly grown larger and more complex, and often involves older populations with co-morbidities and impaired host defenses, resulting in increasing morbidity and mortality. Peer-reviewed literature, clinical guidelines, the evolution of new infections, occurrences of rare infections, advances in treatment options, and federal regulations regarding nonpayment of specific hospital-acquired infections provide a sufficient evidence basis to support the scientific need for this important educational event.

Target Audience
This course is designed for and will benefit physicians, microbiologists, pharmacists, nurse practitioners and physicians’ assistants who are involved with the diagnosis, management, and treatment of infectious diseases, including HIV/AIDS.

Cultural and Linguistic Competency
This activity is in compliance with California Assembly Bill 1195 which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills that enables health care professionals or organizations to care effectively for patients from diverse cultures, groups or communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient’s primary language. Cultural and linguistic competency was incorporated into the planning of this activity. Additional resources on cultural and linguistic competency and information about AB1195 can be found on the UCSD CME website at http://www.cme.ucsd.edu.

Acknowledgement
Multiple supporters from the pharmaceutical industry are being sought for the “36th Remington Winter Course in Infectious Diseases.” Company names will be provided on-site.

Course Objectives
Upon completion of this activity, participants will be able to:

1. Summarize current best practices in the treatment of infection in the transplant patient
2. Discuss emerging treatments and issues associated with infection in the patient with cancer
3. Outline the various approaches to the treatment of fungal infections
4. Describe the pathogenesis and treatment of surgical implant infections
5. Examine the current management of HIV/AIDS, including antiviral therapy, HAART, the role of vaccines, and the management of infections
6. Identify new infections resulting from multi-drug resistance
7. Apply new information gained from broad topic updates in infectious diseases to the diagnosis and treatment of patients

Continuing Education Credit
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of California, San Diego School of Medicine and Winter Course in Infectious Diseases. The University of California, San Diego School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of California, San Diego School of Medicine designates this educational activity for a maximum of 28.5 AMA PRA Category 1 credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Cancellation
If your registration must be cancelled and your request is received in writing on or before February 1, 2010, your paid tuition, less a $50 administrative fee, will be refunded. No refunds will be granted after February 1, 2010.

Modifications
The University of California, San Diego School of Medicine and Winter Course in Infectious Diseases reserve the right to modify the content, faculty and activities and reserve the right to cancel this activity if necessary.

Attire
Casual attire is appropriate throughout the entire meeting

[Return to Top]

Faculty

Faculty Disclosure
It is the policy of the University of California, San Diego School of Continuing Medical Education (UCSD CME) to ensure balance, independence, objectivity and scientific rigor. All faculty participating are required to disclose any real or apparent conflict of interest related to the content of their presentation. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual’s control over the CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All faculty are also required to disclose any discussions of off label/unapproved uses of drugs or devices.

Lawrence K. Altman, MD Clinical Professor, Department of Medicine New York University Medical Center New York, New York		Constance Benson, MD Title TBD Affiliation TBD City, State
Carlos del Rio, MD Professor and Chair Hubert Department of Global Health Division of Infectious Diseases Emory University School of Medicine Atlanta, Georgia		Daniel J. Diekema, MD, MS Associate Professor of Medicine and Pathology Division of Infectious Diseases University of Iowa Health Care Iowa City, Iowa
Marlene L. Durand, MD Director, Infectious Disease Service Massachusetts Eye and Ear Infirmary Associated Physician, Massachusetts General Hospital Assistant Professor, Harvard Medical School Boston, Massachusetts		Patricia Fulco, PharmD, BCPS Virginia Commonwealth University Medical Center Medical College of Virginia Hospitals Richmond, Virginia
Frederick G. Hayden, MD, FACP Stuart S. Richardson Professor of Clinical Virology in Internal Medicine Professor of Internal Medicine and Pathology University of Virginia School of Medicine Charlottesville, Virginia		Michael D. Iseman, MD Chief, Clinical Mycobacteriology Service Division of Infectious Diseases National Jewish Medical and Research Center Professor of Medicine University of Colorado School of Medicine Denver, Colorado
John Jernigan, MD Chief, Interventions and Evaluation Section Division of Healthcare Quality Promotion Centers for Disease Control and Prevention Assistant Professor of Medicine Emory University School of Medicine Atlanta, Georgia		A. W. Karchmer, MD Professor of Medicine, Harvard Medical School Chief, Division of Infectious Diseases Beth Israel Deaconess Medical Center Boston, Massachusett
Jay S. Keystone, MD, FRCPC Professor of Medicine, University of Toronto Tropical Disease Unit, Toronto General Hospital Toronto, Ontario, Canada		Kieran A. Marr, MD Professor of Medicine Director, Transplant and Oncology ID Program Johns Hopkins University, Baltimore, Maryland
José G. Montoya, MD Associate Professor of MedicineDepartment of Medicine Associate Chief for Clinical Affairs Division of Infectious Diseases and Geo. Medicine Stanford University School of Medicine Director, Toxoplasma Serology Laboratory Palo Alto Medical Foundation, Research Institute Palo Alto, California		Peter G. Pappas, MD Professor of Medicine Principal Investigator, Mycoses Study Group Division of Infectious Diseases University of Alabama at Birmingham Birmingham, Alabama
Pierre Rollin, MD Special Pathogens Branch Division of Viral and Rickettsial Diseases Centers for Disease Control, Atlanta, Georgia		W. Michael Scheld, MD Bayer-Gerald L. Mandell Professor of Infectious Diseases Professor of Medicine Clinical Professor of Neurosurgery Director, Pfizer Initiative in International| Health University of Virginia Health System Charlottesville, Virginia
Robert T. Schooley, MD Professor and Head, Division of Infectious Diseases Executive Vice Chairman Department of Medicine University of California, San Diego San Diego, California		J. Scott Weese, DVM, DVSc, DACVIM Assistant Professor Department of Clinical Sciences University of Guelph Guelph, Ontario, Canada
Richard P. Wenzel, MD, MSc William Branch Porter Professor and Chair Department of Internal Medicine Medical College of Virginia Virginia Commonwealth University Richmond, Virginia		Michael T. Wong, MD Assistant Professor of Medicine Harvard Medical School Division of Infectious Diseases Beth Israel Deaconess Medical Center Boston, Massachusetts

[Return to Top]

Agenda
Print formatted version

[Return to Top]

Tuition

This tuition covers all scientific sessions, course materials, planned meal functions and certificate of credit.

Early Bird Registration	Until 1/11/10	$520
Regular Registration	After 1/11/10	$595
Supporters		$475
Fellows, Residents & Students		$150

[Return to Top]

Accommodations
A block of rooms has been secured at the Vail Cascade Hotel & Conference Center for the nights of Saturday, February 20, through Friday, February 26, at a discounted rate of $259 per night for a main lodge room or $299 for a deluxe room, plus applicable taxes and fees. Reservations should be made by contacting the hotel’s Reservations Department directly at 800-420-2424 and identifying yourself as attending the “Winter Course in Infectious Diseases.” All costs, including room, tax, and incidentals, are at your own expense. Full payment for room and tax is due upon booking. The deposit is refundable if notice of cancellation is received no later than 30 days prior to arrival. A limited number of rooms is available for this group, and reservations will be accepted on a first-come, first-served basis. Reservations made after January 15, 2010 will be subject to availability and prevailing room rates.

Vail Cascade Hotel and Conference Center
1300 Westhaven Drive, Vail, Colorado 81657
Hotel Direct: 800-420-2424 • www.vailcascade.com

Americans with Disabilities Act: Grant/Downing Education is fully compliant with ADA regulations. Please contact us at 866-413-1008 if we can assist you with any special needs for this program.

Travel
It is recommended that attendees fly into either Denver International Airport (code “DEN”) or Eagle County Airport (code “EGE”).

The Cascade is located approximately 100 miles west of Denver via Interstate 70 and approximately 35 miles east of the Eagle County Airport via US Highway 6 and Interstate 70.

Ground Transportation
Ground transportation reservations from the airport to the hotel may be made through Colorado Mountain Express.

Phone: 800-525-6363 • Fax: 970-926-9686 • Online: www.ridecme.com

[Return to Top]